Table 1.
Classification | Day symptoms | Nighttime awakenings | Treatment |
---|---|---|---|
Intermittent | ≤2 days/week | ≤2 × /month | Short‐acting B‐agonists |
Mild persistent | >2 days/week | 3–4 × /month | Plus steroid inhalers |
Moderate persistent | Daily | >1 × /week | Plus long‐acting B‐agonists |
Severe persistent | All day | Nightly | Plus oral steroids |
Regular treatment medications were used to classify patients.